Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Preparing for the 2025 healthcare investment landscape — in conversation with Sharon Lamb, Partner at McDermott, Will & Emery

As the healthcare and life sciences sector emerges from a period of consolidation and slower deal activity, investors are eyeing 2025 with cautious optimism. HPE Europe, a conference hosted by multinational law firm McDermott, Will & Emery (MWE), convened in London this autumn to explore key investment themes and strategies for the year ahead, with HBI in attendance.

Sanofi and CD&R enter exclusive agreement for Opella sale, and promise to keep jobs in France

French pharma giant Sanofi and US PE firm Clayton Dubilier & Rice (CD&R) have been made to sign a promise to the French government to keep factories and jobs in France after the sale of a 50% stake in Sanofi's consumer health division, Opella, to CD&R. Sanofi and CD&R are now in exclusive talks for the sale, in a deal which is valuing Opella at $16.4 billion.

UK’s care home sector presents “stable and promising investment opportunity”

Care UK, the fourth largest for-profit care home provider in the UK by revenue, has been sold by British private equity firm Bridgepoint to US-based real estate investment trust (REIT) Welltower. Bridgepoint acquired Care UK for £420 million in 2010, expanding its portfolio from 59 to 163 homes and increasing the proportion of private-pay residents from 5% to over 50%.

Bupa UK offers genome sequencing to selected customers

Bupa is to become the first private healthcare provider in the UK to offer genome sequencing. In a new two-year pilot scheme called ‘My Genomic Health’ the group will offer full genome sequencing to more than 3,500 Bupa UK customers. 

India’s healthcare IPO market grows, presenting fresh opportunities for investors

Niva Bupa Health Insurance, an India-based health insurance firm backed by private equity firm True North, and Paras Healthcare, one of the top Indian private hospitals, have received the Securities and Exchange Board of India’s (SEBI) approval to launch Initial Public Offerings (IPOs). Niva Bupa aims to raise ₹3,000 crore ($361 million USD), comprising Rs 800 crore ($96.4 million USD), through fresh equity and ₹2,200 crore ($264 million USD) via an Offer for Sale (OFS). The Times of India reported in July 2024 that Niva Bupa is “the second standalone health insurer to file an IPO, after Star Health & Allied Insurance Company”, India’s leading health insurer. 

FREE BLOG The HBI Top 100 2024 edition is now live: highlights of what’s in the report

This week HBI is publishing the 2024 edition of our annual ranking of the top 100 healthcare providers in EMEA, based on their 2023 revenue. This marks our fourth year of assessing the largest healthcare service providers in the region, drawing from a comprehensive database of over 5,000 operators. The article, which can be accessed here, examines the top 100 companies, analysing the sectors they operate in, their revenue distribution by sub-sector, ownership type, and provides a country-by-country analysis based on representation.

Parkway Life acquires 11 nursing homes in France from DomusVi

Parkway Life Real Estate Investment Trust (PLife REIT), one of Asia’s largest listed healthcare REITs, has acquired 11 nursing homes in France in a sale and leaseback arrangement for €111.2m (roughly S$159.9 million) from DomusVi, one of Europe’s largest nursing and retirement home providers. The deal marks PLife REIT’s maiden acquisition in Europe, as part of its long-term strategy to grow its presence in the region and the UK. 

Interview: Stéphane Carré, Amethyst Radiotherapy Group

In this interview Stéphane Carré, CEO of pan-European radiotherapy provider Amethyst Radiotherapy, explains how his company is aiming to increase access to state of the art radiotherapy services, and provide a holistic care journey geared towards making the patient feel as comfortable as possible. Stéphane Carré will be sharing more about his business model at HBI 2025, in Paris, March 24-26, 2025.

The HBI Top 100 largest groups in EMEA by revenue 2024 edition

Healthcare Business International has published its fourth annual ranking of EMEA's largest healthcare service providers, drawn from its database of over 5,000 operators. The list, which tracks EMEA-only healthcare service revenues, shows German hospital giant Fresenius Helios maintaining its market leadership with revenues of €12.3bn in 2023.

Find Us